Insider filing · SKYE
Andrew J. Schwab
Director
profile →
Skye Bioscience, Inc.
SKYE · Healthcare · 8 filings in 24 months
ticker →
Andrew J. Schwab sold $770K of Skye Bioscience (SKYE)
Executed Aug 21 2025, disclosed Aug 22 2025, 1 day later.
Value, as filed
$770K
222,621 sh across 2 lots
Executed
Aug 21 2025
the trade date, as filed
Disclosed
Aug 22 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ASAndrew J. Schwab (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in CAMP4 THERAPEUTICS CORPORATION (CAMP). The largest single filing was $1.6M of CAMP (400,000 sh × $4.04, as filed), executed Aug 27.
The name
SKYEHealthcare · Skye Bioscience, Inc., a clinical-stage biotechnology company, develops molecules that modulate G-protein-coupled receptors to treat obesit…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Andrew J. Schwab in SKYE
SKYESALE
Skye Bioscience, Inc.
$185K114,851 sh × $1.61
Exec Sep 23
Filed Sep 24 · 4:31 PM ET